Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1122

1.

Rituximab vs placebo induction prior to glatiramer acetate monotherapy in multiple sclerosis.

Honce JM, Nair KV, Sillau S, Valdez B, Miravalle A, Alvarez E, Schreiner T, Corboy JR, Vollmer TL.

Neurology. 2019 Jan 11. pii: 10.1212/WNL.0000000000006916. doi: 10.1212/WNL.0000000000006916. [Epub ahead of print]

PMID:
30635477
2.

Method to detect ethanol vapour in high humidity by direct reflection on a xerogel coating.

Dalstein O, Tabo M, Alvarez E, Roux L, Garuz R, Pasquinelli M, Azzi L, Bendahan M, Aguir K, Loizillon J, Abbarchi M, Grosso D.

ACS Appl Mater Interfaces. 2019 Jan 10. doi: 10.1021/acsami.8b20479. [Epub ahead of print]

PMID:
30629407
3.

Benchmark Problems for Dynamic Modeling of Intracellular Processes.

Hass H, Loos C, Alvarez ER, Timmer J, Hasenauer J, Kreutz C.

Bioinformatics. 2019 Jan 8. doi: 10.1093/bioinformatics/btz020. [Epub ahead of print]

PMID:
30624608
4.

Critical Illness Causing Marked Hyperlipasemia.

Alvarez E Jr, Persaud R, Soniega-Sherwood J, Rattray J, Richman M.

Am J Med. 2019 Jan 3. pii: S0002-9343(19)30001-4. doi: 10.1016/j.amjmed.2018.12.006. [Epub ahead of print] No abstract available.

PMID:
30611831
5.

RiverCore: IoT Device for River Water Level Monitoring over Cellular Communications.

Moreno C, Aquino R, Ibarreche J, Pérez I, Castellanos E, Álvarez E, Rentería R, Anguiano L, Edwards A, Lepper P, Edwards RM, Clark B.

Sensors (Basel). 2019 Jan 2;19(1). pii: E127. doi: 10.3390/s19010127.

6.

Evaluation of a Novel Preference Assessment Tool for Patients with Multiple Sclerosis.

Col NF, Solomon AJ, Springmann V, Ionete C, Alvarez E, Tierman B, Kutz C, Morales IB, Griffin C, Ngo LH, Jones DE, Phillips G, Hopson A, Pbert L.

Int J MS Care. 2018 Nov-Dec;20(6):260-267. doi: 10.7224/1537-2073.2017-021.

7.

Why Uruguay legalized marijuana? The open window of public insecurity.

Queirolo R, Rossel C, Álvarez E, Repetto L.

Addiction. 2018 Dec 11. doi: 10.1111/add.14523. [Epub ahead of print]

PMID:
30536953
8.

[Histoplasma capsulatum: an emerging agent in Chile?]

Álvarez E, Amaro J, Villavicencio L.

Rev Chilena Infectol. 2018;35(3):309-311. doi: 10.4067/s0716-10182018000300309. Spanish.

9.

Exploring cannabis use by patients with multiple sclerosis in a state where cannabis is legal.

Weinkle L, Domen CH, Shelton I, Sillau S, Nair K, Alvarez E.

Mult Scler Relat Disord. 2018 Nov 20;27:383-390. doi: 10.1016/j.msard.2018.11.022. [Epub ahead of print]

PMID:
30502644
10.

Hydroboration of carbon dioxide with catechol- and pinacolborane using an Ir-CNP* pincer complex. Water influence on the catalytic activity.

Sánchez P, Hernández-Juárez M, Rendón N, López-Serrano J, Álvarez E, Paneque M, Suárez A.

Dalton Trans. 2018 Nov 27;47(46):16766-16776. doi: 10.1039/c8dt03951h.

PMID:
30427345
11.

Ayahuasca improves emotion dysregulation in a community sample and in individuals with borderline-like traits.

Domínguez-Clavé E, Soler J, Pascual JC, Elices M, Franquesa A, Valle M, Alvarez E, Riba J.

Psychopharmacology (Berl). 2018 Nov 7. doi: 10.1007/s00213-018-5085-3. [Epub ahead of print]

PMID:
30406413
12.

We need to conduct clinical trials of disease-modifying therapy in pregnancy to optimize care of women with MS - Yes.

Alvarez E, Mowry EM.

Mult Scler. 2018 Oct 22:1352458518794061. doi: 10.1177/1352458518794061. [Epub ahead of print] No abstract available.

PMID:
30346221
13.

Impact of fingolimod on clinical and magnetic resonance imaging outcomes in routine clinical practice: A retrospective analysis of the multiple sclerosis, clinical and MRI outcomes in the USA (MS-MRIUS) study.

Zivadinov R, Medin J, Khan N, Korn JR, Chitnis T, Naismith RT, Alvarez E, Dwyer MG, Bergsland N, Carl E, Silva D, Weinstock-Guttman B; MS-MRIUS Study Group.

Mult Scler Relat Disord. 2018 Oct 3;27:65-73. doi: 10.1016/j.msard.2018.09.037. [Epub ahead of print]

PMID:
30342416
14.

Synthesis, Structure and Nickel Carbonyl Complexes of Dialkylterphenyl Phosphines.

Marín M, Moreno JJ, Navarro-Gilabert C, Álvarez E, Maya C, Peloso R, Nicasio MC, Carmona E.

Chemistry. 2019 Jan 2;25(1):260-272. doi: 10.1002/chem.201803598. Epub 2018 Nov 19.

PMID:
30290026
15.

Pas Kinase Deficiency Triggers Antioxidant Mechanisms in the Liver.

Dongil P, Pérez-García A, Hurtado-Carneiro V, Herrero-de-Dios C, Blazquez E, Alvarez E, Sanz C.

Sci Rep. 2018 Sep 14;8(1):13810. doi: 10.1038/s41598-018-32192-w.

16.

Strategies to improve adherence to antiretroviral therapy and retention in care for people living with HIV in high-income countries: a protocol for an overview of systematic reviews.

Mbuagbaw L, Mertz D, Lawson DO, Smieja M, Benoit AC, Alvarez E, Puchalski Ritchie L, Rachlis B, Logie C, Husbands W, Margolese S, Thabane L.

BMJ Open. 2018 Sep 11;8(9):e022982. doi: 10.1136/bmjopen-2018-022982.

17.

End-of-Life Care Intensity in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation: A Population-Level Analysis.

Johnston EE, Muffly L, Alvarez E, Saynina O, Sanders LM, Bhatia S, Chamberlain LJ.

J Clin Oncol. 2018 Sep 5:JCO2018780957. doi: 10.1200/JCO.2018.78.0957. [Epub ahead of print]

PMID:
30183467
18.

Double A3 -Coupling of Primary Amines Catalysed by Gold Complexes.

Grirrane A, Álvarez E, García H, Corma A.

Chemistry. 2018 Nov 2;24(61):16356-16367. doi: 10.1002/chem.201803020. Epub 2018 Oct 11.

PMID:
30175862
19.

Atorvastatin, but not pravastatin, inhibits cardiac Akt/mTOR signaling and disturbs mitochondrial ultrastructure in cardiac myocytes.

Godoy JC, Niesman IR, Busija AR, Kassan A, Schilling JM, Schwarz A, Alvarez EA, Dalton ND, Drummond JC, Roth DM, Kararigas G, Patel HH, Zemljic-Harpf AE.

FASEB J. 2019 Jan;33(1):1209-1225. doi: 10.1096/fj.201800876R. Epub 2018 Aug 31.

PMID:
30169110
20.

Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis.

Fox RJ, Coffey CS, Conwit R, Cudkowicz ME, Gleason T, Goodman A, Klawiter EC, Matsuda K, McGovern M, Naismith RT, Ashokkumar A, Barnes J, Ecklund D, Klingner E, Koepp M, Long JD, Natarajan S, Thornell B, Yankey J, Bermel RA, Debbins JP, Huang X, Jagodnik P, Lowe MJ, Nakamura K, Narayanan S, Sakaie KE, Thoomukuntla B, Zhou X, Krieger S, Alvarez E, Apperson M, Bashir K, Cohen BA, Coyle PK, Delgado S, Dewitt LD, Flores A, Giesser BS, Goldman MD, Jubelt B, Lava N, Lynch SG, Moses H, Ontaneda D, Perumal JS, Racke M, Repovic P, Riley CS, Severson C, Shinnar S, Suski V, Weinstock-Guttman B, Yadav V, Zabeti A; NN102/SPRINT-MS Trial Investigators.

N Engl J Med. 2018 Aug 30;379(9):846-855. doi: 10.1056/NEJMoa1803583.

PMID:
30157388
21.

Discontinuation and comparative effectiveness of dimethyl fumarate and fingolimod in 2 centers.

Vollmer B, Ontaneda D, Bandyopadhyay A, Cohn S, Nair K, Sillau S, Bermel RA, Corboy JR, Fox RJ, Vollmer T, Cohen JA, Alvarez E, Hersh CM.

Neurol Clin Pract. 2018 Aug;8(4):292-301. doi: 10.1212/CPJ.0000000000000487.

22.

Association of Either Left Ventricular Hypertrophy or Diastolic Dysfunction With 24-Hour Central and Peripheral Blood Pressure.

Blanch P, Armario P, Oliveras A, Fernández-Llama P, Vázquez S, Pareja J, Álvarez E, Calero F, Sierra C, de la Sierra A.

Am J Hypertens. 2018 Nov 13;31(12):1293-1299. doi: 10.1093/ajh/hpy123.

PMID:
30084975
23.

Does Treatment Setting Matter? Evaluating Resource Utilization for Adolescents Treated in Pediatric vs Adult Cancer Institutions.

Parsons HM, Muffly L, Alvarez EM, Keegan THM.

J Natl Cancer Inst. 2018 Jul 19. doi: 10.1093/jnci/djy123. [Epub ahead of print] No abstract available.

PMID:
30053066
24.

PAS Kinase deficiency alters the glucokinase function and hepatic metabolism.

Pérez-García A, Dongil P, Hurtado-Carneiro V, Blazquez E, Sanz C, Alvarez E.

Sci Rep. 2018 Jul 23;8(1):11091. doi: 10.1038/s41598-018-29234-8.

25.

Discovery of a Potent α-Galactosidase Inhibitor by in Situ Analysis of a Library of Pyrrolizidine-(Thio)urea Hybrid Molecules Generated via Click Chemistry.

Elías-Rodríguez P, Pingitore V, Carmona AT, Moreno-Vargas AJ, Ide D, Miyawaki S, Kato A, Álvarez E, Robina I.

J Org Chem. 2018 Aug 17;83(16):8863-8873. doi: 10.1021/acs.joc.8b01073. Epub 2018 Aug 1.

PMID:
30014697
26.

Haplosporidium pinnae sp. nov., a haplosporidan parasite associated with mass mortalities of the fan mussel, Pinna nobilis, in the Western Mediterranean Sea.

Catanese G, Grau A, Valencia JM, Garcia-March JR, Vázquez-Luis M, Alvarez E, Deudero S, Darriba S, Carballal MJ, Villalba A.

J Invertebr Pathol. 2018 Sep;157:9-24. doi: 10.1016/j.jip.2018.07.006. Epub 2018 Jul 10.

PMID:
30005968
27.

Azabora[5]helicene Charge-Transfer Dyes Show Efficient and Spectrally Variable Circularly Polarized Luminescence.

Domínguez Z, López-Rodríguez R, Álvarez E, Abbate S, Longhi G, Pischel U, Ros A.

Chemistry. 2018 Aug 27;24(48):12660-12668. doi: 10.1002/chem.201801908. Epub 2018 Jul 23.

PMID:
29901866
28.

Looking into the effect of multi-item symptom domains on psychometric characteristics of the Quick Inventory of Depressive Symptomatology-Self Report (QIDS-SR16).

Trujols J, de Diego-Adeliño J, Feliu-Soler A, Iraurgi I, Puigdemont D, Álvarez E, Pérez V, Portella MJ.

Psychiatry Res. 2018 Sep;267:126-130. doi: 10.1016/j.psychres.2018.05.076. Epub 2018 May 31.

PMID:
29890375
29.

The impact of very short transition times on switching from Natalizumab to Fingolimod on imaging and clinical effectiveness outcomes in multiple sclerosis.

Vollmer B, Honce JM, Sillau S, Corboy JR, Vollmer T, Nair K, Alvarez E.

J Neurol Sci. 2018 Jul 15;390:89-93. doi: 10.1016/j.jns.2018.04.021. Epub 2018 Apr 13.

PMID:
29801915
30.

Lewis Base/Bronsted Acid Dual-Catalytic C-H Sulfenylation of Aromatics.

Nalbandian CJ, Brown ZE, Alvarez E, Gustafson JL.

Org Lett. 2018 Jun 1;20(11):3211-3214. doi: 10.1021/acs.orglett.8b01066. Epub 2018 May 15.

PMID:
29762039
31.

Fingolimod's Impact on MRI Brain Volume Measures in Multiple Sclerosis: Results from MS-MRIUS.

Zivadinov R, Medin J, Khan N, Korn JR, Bergsland N, Dwyer MG, Chitnis T, Naismith RT, Alvarez E, Kinkel P, Cohan S, Hunter SF, Silva D, Weinstock-Guttman B; MS-MRIUS investigators.

J Neuroimaging. 2018 Jul;28(4):399-405. doi: 10.1111/jon.12518. Epub 2018 May 11.

PMID:
29749661
32.

Patient characteristics driving clinical utility in psychiatric pharmacogenetics: a reanalysis from the AB-GEN multicentric trial.

Menchón JM, Espadaler J, Tuson M, Saiz-Ruiz J, Bobes J, Vieta E, Álvarez E, Pérez V.

J Neural Transm (Vienna). 2018 May 4. doi: 10.1007/s00702-018-1879-z. [Epub ahead of print]

PMID:
29728861
33.

Patterns of care and outcomes in adolescent and young adult acute lymphoblastic leukemia: a population-based study.

Muffly L, Alvarez E, Lichtensztajn D, Abrahão R, Gomez SL, Keegan T.

Blood Adv. 2018 Apr 24;2(8):895-903. doi: 10.1182/bloodadvances.2017014944.

34.

Sociodemographic disparities in the occurrence of medical conditions among adolescent and young adult Hodgkin lymphoma survivors.

Keegan THM, Li Q, Steele A, Alvarez EM, Brunson A, Flowers CR, Glaser SL, Wun T.

Cancer Causes Control. 2018 Jun;29(6):551-561. doi: 10.1007/s10552-018-1025-0. Epub 2018 Apr 13.

PMID:
29654427
35.

High-fat diet alters PAS kinase regulation by fasting and feeding in liver.

Pérez-García A, Dongil P, Hurtado-Carneiro V, Blázquez E, Sanz C, Álvarez E.

J Nutr Biochem. 2018 Jul;57:14-25. doi: 10.1016/j.jnutbio.2018.03.003. Epub 2018 Mar 12.

PMID:
29649689
36.

Burnout and posttraumatic stress in paediatric critical care personnel: Prediction from resilience and coping styles.

Rodríguez-Rey R, Palacios A, Alonso-Tapia J, Pérez E, Álvarez E, Coca A, Mencía S, Marcos A, Mayordomo-Colunga J, Fernández F, Gómez F, Cruz J, Ordóñez O, Llorente A.

Aust Crit Care. 2019 Jan;32(1):46-53. doi: 10.1016/j.aucc.2018.02.003. Epub 2018 Mar 28.

PMID:
29605169
37.

Hydrogenation of an iridium-coordinated imidazol-2-ylidene ligand fragment.

Hernández-Juárez M, López-Serrano J, González-Herrero P, Rendón N, Álvarez E, Paneque M, Suárez A.

Chem Commun (Camb). 2018 Apr 12;54(31):3843-3846. doi: 10.1039/c8cc00420j.

PMID:
29594309
38.

Pretransplant IgA-Anti-Beta 2 Glycoprotein I Antibodies As a Predictor of Early Graft Thrombosis after Renal Transplantation in the Clinical Practice: A Multicenter and Prospective Study.

Morales JM, Serrano M, Martinez-Flores JA, Gainza FJ, Marcen R, Arias M, Escuin F, Pérez D, Andres A, Martínez MA, Maruri N, Alvarez E, Castañer JL, López-Hoyos M, Serrano A.

Front Immunol. 2018 Mar 12;9:468. doi: 10.3389/fimmu.2018.00468. eCollection 2018.

39.

Identifying inhibitors of the Leishmania inositol phosphorylceramide synthase with antiprotozoal activity using a yeast-based assay and ultra-high throughput screening platform.

Norcliffe JL, Mina JG, Alvarez E, Cantizani J, de Dios-Anton F, Colmenarejo G, Valle SG, Marco M, Fiandor JM, Martin JJ, Steel PG, Denny PW.

Sci Rep. 2018 Mar 2;8(1):3938. doi: 10.1038/s41598-018-22063-9.

40.
41.

h-caldesmon immunoreactivity in atypical fibroxanthoma: implications for the differential diagnosis.

Martinez-Ciarpaglini C, Agustí J, Alvarez E, Hueso L, Terrádez L, Monteagudo C.

Pathology. 2018 Apr;50(3):358-361. doi: 10.1016/j.pathol.2017.09.020. Epub 2018 Mar 1. No abstract available.

PMID:
29490873
42.

Cognitive predictors of illness course at 12 months after first-episode of depression.

Vicent-Gil M, Keymer-Gausset A, Serra-Blasco M, Carceller-Sindreu M, de Diego-Adeliño J, Trujols J, Mur M, Pérez V, Alvarez E, Cardoner N, Portella MJ.

Eur Neuropsychopharmacol. 2018 Apr;28(4):529-537. doi: 10.1016/j.euroneuro.2018.02.001. Epub 2018 Feb 23.

PMID:
29482974
43.

The Role of Artificial Intelligence in Diagnostic Radiology: A Survey at a Single Radiology Residency Training Program.

Collado-Mesa F, Alvarez E, Arheart K.

J Am Coll Radiol. 2018 Dec;15(12):1753-1757. doi: 10.1016/j.jacr.2017.12.021. Epub 2018 Feb 21.

PMID:
29477289
44.

Determination of hemodynamic risk for vascular disease in planar artery bifurcations.

Otero-Cacho A, Aymerich M, Flores-Arias MT, Abal M, Álvarez E, Pérez-Muñuzuri V, Muñuzuri AP.

Sci Rep. 2018 Feb 12;8(1):2795. doi: 10.1038/s41598-018-21126-1.

45.

Care at specialized cancer centers among young adults with acute lymphoblastic leukemia in California.

Alvarez E, Muffly L, Li Q, Brunson A, Wun T, Chamberlain L, Keegan T.

Leuk Lymphoma. 2018 Oct;59(10):2482-2484. doi: 10.1080/10428194.2018.1427856. Epub 2018 Feb 9. No abstract available.

PMID:
29424251
46.

Glycation of human serum albumin impairs binding to the glucagon-like peptide-1 analogue liraglutide.

Gajahi Soudahome A, Catan A, Giraud P, Assouan Kouao S, Guerin-Dubourg A, Debussche X, Le Moullec N, Bourdon E, Bravo SB, Paradela-Dobarro B, Álvarez E, Meilhac O, Rondeau P, Couprie J.

J Biol Chem. 2018 Mar 30;293(13):4778-4791. doi: 10.1074/jbc.M117.815274. Epub 2018 Feb 2.

PMID:
29414771
47.

Inpatient utilization and disparities: The last year of life of adolescent and young adult oncology patients in California.

Johnston EE, Alvarez E, Saynina O, Sanders LM, Bhatia S, Chamberlain LJ.

Cancer. 2018 Apr 15;124(8):1819-1827. doi: 10.1002/cncr.31233. Epub 2018 Feb 2.

PMID:
29393967
48.

Pathological Response in a Triple-Negative Breast Cancer Cohort Treated with Neoadjuvant Carboplatin and Docetaxel According to Lehmann's Refined Classification.

Echavarria I, López-Tarruella S, Picornell A, García-Saenz JÁ, Jerez Y, Hoadley K, Gómez HL, Moreno F, Monte-Millan MD, Márquez-Rodas I, Alvarez E, Ramos-Medina R, Gayarre J, Massarrah T, Ocaña I, Cebollero M, Fuentes H, Barnadas A, Ballesteros AI, Bohn U, Perou CM, Martin M.

Clin Cancer Res. 2018 Apr 15;24(8):1845-1852. doi: 10.1158/1078-0432.CCR-17-1912. Epub 2018 Jan 29.

PMID:
29378733
49.

Impact of interferon-free regimens on the glomerular filtration rate during treatment of chronic hepatitis C in a real-life cohort.

Álvarez-Ossorio MJ, Sarmento E Castro R, Granados R, Macías J, Morano-Amado LE, Ríos MJ, Merino D, Álvarez EN, Collado A, Pérez-Pérez M, Téllez F, Martín JM, Méndez J, Pineda JA, Neukam K; HEPAVIR-DAA, GEHEP-MONO, RIS-HEP07 and RIS-HEP13 Study Groups.

J Viral Hepat. 2018 Jun;25(6):699-706. doi: 10.1111/jvh.12867. Epub 2018 Feb 27.

PMID:
29377515
50.

Pulse Width Does Not Influence the Gains Achieved With Neuromuscular Electrical Stimulation in People With Multiple Sclerosis: Double-Blind, Randomized Trial.

Almuklass AM, Davis L, Hamilton LD, Hebert JR, Alvarez E, Enoka RM.

Neurorehabil Neural Repair. 2018 Jan;32(1):84-93. doi: 10.1177/1545968317753681. Epub 2018 Jan 24.

PMID:
29366377

Supplemental Content

Loading ...
Support Center